Tracking a heart medication for adults born with heart defects

This international study is tracking how a medication called SGLT2 inhibitors (SGLT2i) works in adults born with heart defects. Researchers want to understand whether this medication—which has shown promise in treating other types of heart failure—can help people with congenital heart disease who are experiencing heart failure. The study collects real-world information from your regular medical visits, with no additional tests or procedures required.

Heart failure is the main health problem affecting adults who were born with heart defects, but doctors don't have much evidence about which medications work best for this specific group. This medication has been very helpful for other types of heart failure, so researchers want to learn whether it's also safe and effective for people with congenital heart disease.